Cannasouth Limited (NZX:CBD) announces the appointment of David Petterson as a director of the following subsidiaries:
1. Cannasouth Cultivation Limited;
2. Eqalis Group New Zealand Limited;
3. Eqalis Innovations Limited;
4. Eqalis Pharmaceuticals Limited; and
5. Restoreme Clinic Limited,
and that Mark Lucas and Colin Foster are no longer directors of those companies.
The above changes are effective from 16 August 2024.
-ENDS-
For further information visit www.cannasouth.co.nz or contact:
Garry Whimp Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 587 230
Ben Francis
Administrator, Blacklock Rose Ltd
Email: [email protected]
Mobile: 021 042 6991
The S&P/ASX 200 has recovered from the US's so-called "Liberation Day".
It will close at the end of July, affecting 120 jobs.
The median price for Cxbladder Triage Plus is US$1,018.44.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details